Skip to main content

New and competing renewal awards for October 2019

Friday, November 15, 2019
McGovern Davison Children's Health Center

The following are new and competing renewal awards made to faculty in the Department of Pediatrics through the month of October 2019. Please extend your congratulations to these individuals.

Kaveh Ardalan, MD (Rheumatology) received an award from Childhood Arthritis & Rheumatology Research Alliance, Inc. in the amount of 19,872 for a research study entitled “CARRA Early Investigator Vice Chair Support.” The project period is 10/01/2019 – 06/30/2021.

Rasheed Gbadegesin, MBBS (Nephrology) received an award from Nationwide Children’ in the amount of $105,581 for a research study entitled “CUREGN 2.0 Midwest Pediatric Nephrology Consortium-PCC”.  The project period is 07/01/2019-06/30/2024.

Salim Idriss, MD, PhD (Cardiology) received an award from Food and Drug Administration in the amount $333,751 for a research study entitled “CSRC Prevention of Sudden Cardiac Death in the Young: National Cardiac Screening Warehouse Pilot Study”.  The project period is 09/30/2019-09/29/2020.

Dwight Koeberl, MD, PhD (Medical Genetics) received an award from Moderna Therapeutics in the amount of $364,669 for a research study entitled “A global Phase 1/2, Open Label Dose Escalation Study to Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of mRNA-3704 in Patients with Isolated Methylmalonic Acidemai Due to Methylmalonyl-CoA Mutase Deficiency”.  The project period is 10/01/2019-09/30/2023.

Jennifer Peterson, MD (Neonatology) received an award from Prolacta in the amount of $57,275 for a research study entitled “Effects of an Exclusive Human Milk Diet on Enteral Feeding Outcomes of Neonates with Congenital Gastrointestinal Disorders”.  The project period is 09/17/2019-11/16/2020.

Jennifer Rothman, MD (Hematology-Oncology) received an award from Novartis (ICON-3) in the amount of $53,275 for a research study entitled “A Phase 3 Study of Eltrombopag vs Standard First-Line Management of Newly Diagnosed Immune Thrombocytopenia (ITP) in children”.  The project period is 10/10/2019-06/30/2021.

Jennifer Sherwin, MD (Critical Care Medicine) received an award from Pfizer Inc. in the amount of $329,160 for a research project entitled “CAZ-AVI (Cefazidime-Avibactam)”.  The project period is 09/10/2019-09/30/2022.

Baodong Sun, PhD (Medical Genetics) received an award from Asklepios BioPharmaceutical, Inc. in the amount of $208,223 for a research study entitled “Vector Development”.  The project period is 10/01/2019-07/31/2020.

Lars Wagner, MD (Hematology-Oncology) received an award from Children’s Hospital of Philadelphia/Pfizer in the amount of $4,500 for a research study entitled “A phase 2 Study of Inotuzumab Ozogamicin in Children and Young Adults with Relapsed or Refractory CD22+B-Actue Lymphoblastic Leukemia”. The project period is 06/01/2019-06/30/2026.

Lars Wagner, MD (Hematology-Oncology) received an award from Gradalis, Inc. in the amount of $277,441 for a research project entitled “A Multi-Center Phase III, Randomized Open-Label Trail of Vigil (bi-shRNAfurin and GMCSF Augmented Autologous Tumor Cell Immunotherapy) in combination with Irinotecan and Temozolomide as a Second-Regimen for Ewing's Sarcoma”.  The project period is 10/01/2019-10/31/2023.

Emmanuel B. Walter, MD (Infectious Diseases) received an award from National Institutes of Health in the amount of $7,894,646 for a research study entitled “Collaborative Influenza Vaccine Innovation Centers (CIVICS) Component C: Clinical Core- Option 16." The project period is 09/16/2019 – 09/15/2022.

Congratulations to these faculty on their awards and best wishes to them in their investigative work.

Coleen K. Cunningham, MD
Vice Chair, Research
Professor of Pediatrics
Division of Infectious Diseases
Chief, Division of Global Health